Skip to content

DICE THERAPEUTICS, INC.

CIK 0001645569

← back to feed
Revenue (TTM)
$1.13M
+30.4% YoY Q2 Jul 2023
Net Income (TTM)
−$102.53M
−71.3% YoY Q2 Jul 2023
EPS Diluted (TTM)
−$2.41
+46.1% YoY Q2 Jul 2023
Gross Margin
—
Q2 Jul 2023
Operating Margin
-10,132.0%
Q2 Jul 2023
Net Margin
-9,114.1%
Q2 Jul 2023
Free Cash Flow (TTM)
−$66.56M
Q2 Jul 2023
Cash
$73.46M
Q2 Jul 2023
Total Debt
$2.42M
Q2 Jul 2023
Shares Outstanding
47.79M sh
Q2 Jul 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings